http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 12 Mar 2026 16:03:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++HeartBeam%2C+Inc.+++++++++++For%3A+Dec+31/26152829.html si-local-file:///var/storage/secattach/20260312/26152829.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++HeartBeam%2C+Inc.+++++++++++For%3A+Dec+31/26152829.html Thu, 12 Mar 2026 16:03:00 -0400 BEAT O.52737737 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++HeartBeam%2C+Inc.+++++++++++For%3A+Dec+31/26152829.html si-local-file:///var/storage/secattach/20260312/26152829.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++HeartBeam%2C+Inc.+++++++++++For%3A+Dec+31/26152829.html Thu, 12 Mar 2026 16:03:00 -0400 BEAT O.52737737 http://www.streetinsider.com/Earnings/HeartBeam%2C+Inc+%28BEAT%29+Misses+Q4+EPS+by+46c/26152787.html <p>HeartBeam, Inc (NASDAQ: BEAT) reported Q4 EPS of ($0.62), $0.46 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .</p><p>For earnings history and earnings-related data on HeartBeam, Inc (BEAT) <a href="http://www.streetinsider.com/ec_earnings.php?q=BEAT">click here</a>.</p> http://www.streetinsider.com/Earnings/HeartBeam%2C+Inc+%28BEAT%29+Misses+Q4+EPS+by+46c/26152787.html Thu, 12 Mar 2026 16:01:49 -0400 BEAT http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html <ul class="bwlistdisc"> <li> <i>HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</i> </li> <li> <i>First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market</i> </li> <li> <i>First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Completed the First Working Prototype of an Extended-Wear 12-Lead ECG Patch</i> </li> <li> <i>Strategic Collaboration with the Icahn School of Medicine at Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul><p>   </p> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54447054&amp;newsitemid=20260312059838&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=7341037a1173bf54e45a91c736c7a913" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html Thu, 12 Mar 2026 16:01:00 -0400 A.06822034 A.23636062 BEAT O.20026344 O.41740509 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html <ul class="bwlistdisc"> <li> <i>HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</i> </li> <li> <i>First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market</i> </li> <li> <i>First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Completed the First Working Prototype of an Extended-Wear 12-Lead ECG Patch</i> </li> <li> <i>Strategic Collaboration with the Icahn School of Medicine at Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul><p>   </p> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54447054&amp;newsitemid=20260312059838&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=7341037a1173bf54e45a91c736c7a913" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html Thu, 12 Mar 2026 16:01:00 -0400 A.06822034 A.23636062 BEAT O.20026344 O.41740509 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html <ul class="bwlistdisc"> <li> <i>HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</i> </li> <li> <i>First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market</i> </li> <li> <i>First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Completed the First Working Prototype of an Extended-Wear 12-Lead ECG Patch</i> </li> <li> <i>Strategic Collaboration with the Icahn School of Medicine at Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul><p>   </p> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54447054&amp;newsitemid=20260312059838&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=7341037a1173bf54e45a91c736c7a913" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html Thu, 12 Mar 2026 16:01:00 -0400 A.06822034 A.23636062 BEAT O.20026344 O.41740509 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html <ul class="bwlistdisc"> <li> <i>HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</i> </li> <li> <i>First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market</i> </li> <li> <i>First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Completed the First Working Prototype of an Extended-Wear 12-Lead ECG Patch</i> </li> <li> <i>Strategic Collaboration with the Icahn School of Medicine at Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul><p>   </p> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54447054&amp;newsitemid=20260312059838&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=7341037a1173bf54e45a91c736c7a913" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html Thu, 12 Mar 2026 16:01:00 -0400 A.06822034 A.23636062 BEAT O.20026344 O.41740509 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html <ul class="bwlistdisc"> <li> <i>HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</i> </li> <li> <i>First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market</i> </li> <li> <i>First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Completed the First Working Prototype of an Extended-Wear 12-Lead ECG Patch</i> </li> <li> <i>Strategic Collaboration with the Icahn School of Medicine at Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul><p>   </p> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54447054&amp;newsitemid=20260312059838&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=7341037a1173bf54e45a91c736c7a913" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html Thu, 12 Mar 2026 16:01:00 -0400 A.06822034 A.23636062 BEAT O.20026344 O.41740509 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html <ul class="bwlistdisc"> <li> <i>HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</i> </li> <li> <i>First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market</i> </li> <li> <i>First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Completed the First Working Prototype of an Extended-Wear 12-Lead ECG Patch</i> </li> <li> <i>Strategic Collaboration with the Icahn School of Medicine at Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul><p>   </p> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54447054&amp;newsitemid=20260312059838&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=7341037a1173bf54e45a91c736c7a913" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a http://www.streetinsider.com/Press+Releases/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html Thu, 12 Mar 2026 16:01:00 -0400 A.06822034 A.23636062 BEAT O.20026344 O.41740509 O.52737737 http://www.streetinsider.com/Business+Wire/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html <ul class="bwlistdisc"> <li> <i>HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</i> </li> <li> <i>First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market</i> </li> <li> <i>First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Completed the First Working Prototype of an Extended-Wear 12-Lead ECG Patch</i> </li> <li> <i>Strategic Collaboration with the Icahn School of Medicine at Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul><p>   </p> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54447054&amp;newsitemid=20260312059838&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=7341037a1173bf54e45a91c736c7a913" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a http://www.streetinsider.com/Business+Wire/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html Thu, 12 Mar 2026 16:01:00 -0400 A.06822034 A.23636062 BEAT O.20026344 O.41740509 O.52737737 http://www.streetinsider.com/Business+Wire/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html <ul class="bwlistdisc"> <li> <i>HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</i> </li> <li> <i>First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market</i> </li> <li> <i>First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Completed the First Working Prototype of an Extended-Wear 12-Lead ECG Patch</i> </li> <li> <i>Strategic Collaboration with the Icahn School of Medicine at Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul><p>   </p> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54447054&amp;newsitemid=20260312059838&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=7341037a1173bf54e45a91c736c7a913" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a http://www.streetinsider.com/Business+Wire/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html Thu, 12 Mar 2026 16:01:00 -0400 A.06822034 A.23636062 BEAT O.20026344 O.41740509 O.52737737 http://www.streetinsider.com/Business+Wire/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html <ul class="bwlistdisc"> <li> <i>HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</i> </li> <li> <i>First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market</i> </li> <li> <i>First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Completed the First Working Prototype of an Extended-Wear 12-Lead ECG Patch</i> </li> <li> <i>Strategic Collaboration with the Icahn School of Medicine at Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul><p>   </p> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54447054&amp;newsitemid=20260312059838&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=7341037a1173bf54e45a91c736c7a913" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a http://www.streetinsider.com/Business+Wire/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html Thu, 12 Mar 2026 16:01:00 -0400 A.06822034 A.23636062 BEAT O.20026344 O.41740509 O.52737737 http://www.streetinsider.com/Business+Wire/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html <ul class="bwlistdisc"> <li> <i>HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</i> </li> <li> <i>First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market</i> </li> <li> <i>First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Completed the First Working Prototype of an Extended-Wear 12-Lead ECG Patch</i> </li> <li> <i>Strategic Collaboration with the Icahn School of Medicine at Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul><p>   </p> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54447054&amp;newsitemid=20260312059838&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=7341037a1173bf54e45a91c736c7a913" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a http://www.streetinsider.com/Business+Wire/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html Thu, 12 Mar 2026 16:01:00 -0400 A.06822034 A.23636062 BEAT O.20026344 O.41740509 O.52737737 http://www.streetinsider.com/Business+Wire/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html <ul class="bwlistdisc"> <li> <i>HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</i> </li> <li> <i>First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market</i> </li> <li> <i>First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Completed the First Working Prototype of an Extended-Wear 12-Lead ECG Patch</i> </li> <li> <i>Strategic Collaboration with the Icahn School of Medicine at Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul><p>   </p> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54447054&amp;newsitemid=20260312059838&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=7341037a1173bf54e45a91c736c7a913" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a http://www.streetinsider.com/Business+Wire/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html Thu, 12 Mar 2026 16:01:00 -0400 A.06822034 A.23636062 BEAT O.20026344 O.41740509 O.52737737 http://www.streetinsider.com/Business+Wire/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html <ul class="bwlistdisc"> <li> <i>HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</i> </li> <li> <i>First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market</i> </li> <li> <i>First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion</i> </li> <li> <i>Completed the First Working Prototype of an Extended-Wear 12-Lead ECG Patch</i> </li> <li> <i>Strategic Collaboration with the Icahn School of Medicine at Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms</i> </li> <li> <i>Management to Host Webcast and Conference Call Today at 4:30 p.m. ET</i> </li> </ul><p>   </p> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54447054&amp;newsitemid=20260312059838&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=7341037a1173bf54e45a91c736c7a913" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a http://www.streetinsider.com/Business+Wire/HeartBeam+Reports+Fourth+Quarter+and+Full+Year+2025+Results/26152755.html Thu, 12 Mar 2026 16:01:00 -0400 A.06822034 A.23636062 BEAT O.20026344 O.41740509 O.52737737 http://www.streetinsider.com/Corporate+News/HeartBeam+partners+with+Mount+Sinai+on+AI+cardiac+monitoring+development/26135166.html <p>HeartBeam Inc. (NASDAQ: BEAT) announced a collaboration with the Icahn School of Medicine at Mount Sinai to develop AI-ECG algorithms for cardiac monitoring applications. The partnership combines HeartBeam's 3D ECG signal collection technology with Mount Sinai's clinical data and artificial intelligence expertise.</p><p>The collaboration aims to create AI models using HeartBeam's synthesized 12-lead ECG data collected from patients in home settings. Mount Sinai will contribute clinically annotated 12-lead ECG data to train and validate various AI algorithms intended for deployment on HeartBeam's platform.</p><p>HeartBeam's technology captures heart electrical activity from three non-coplanar dimensions without cables, enabling 12-lead ECG data collection outside traditional http://www.streetinsider.com/Corporate+News/HeartBeam+partners+with+Mount+Sinai+on+AI+cardiac+monitoring+development/26135166.html Tue, 10 Mar 2026 07:01:34 -0400 BEAT http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html <ul class="bwlistdisc"> <li> <i>Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk</i> </li> <li> <i>Combines Mount Sinai’s world-class AI and clinical expertise with HeartBeam’s groundbreaking 3D ECG signal collection technology</i> </li> <li> <i>HeartBeam is the only platform capable of collecting 12-lead ECG data from patients anytime, anywhere, over time – extending access beyond traditional clinical settings</i> </li> <li> <i>Positions HeartBeam to expand from symptom-based cardiac rhythm monitoring into AI-enabled disease assessment and management</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54443010&amp;newsitemid=20260310761343&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=518c515ad0d59d148ca75231485e1ac1" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html Tue, 10 Mar 2026 07:00:00 -0400 A.00796151 A.23636062 A.30645299 A.50208664 BEAT O.00786879 O.40299161 O.41740509 O.48172734 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html <ul class="bwlistdisc"> <li> <i>Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk</i> </li> <li> <i>Combines Mount Sinai’s world-class AI and clinical expertise with HeartBeam’s groundbreaking 3D ECG signal collection technology</i> </li> <li> <i>HeartBeam is the only platform capable of collecting 12-lead ECG data from patients anytime, anywhere, over time – extending access beyond traditional clinical settings</i> </li> <li> <i>Positions HeartBeam to expand from symptom-based cardiac rhythm monitoring into AI-enabled disease assessment and management</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54443010&amp;newsitemid=20260310761343&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=518c515ad0d59d148ca75231485e1ac1" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html Tue, 10 Mar 2026 07:00:00 -0400 A.00796151 A.23636062 A.30645299 A.50208664 BEAT O.00786879 O.40299161 O.41740509 O.48172734 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html <ul class="bwlistdisc"> <li> <i>Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk</i> </li> <li> <i>Combines Mount Sinai’s world-class AI and clinical expertise with HeartBeam’s groundbreaking 3D ECG signal collection technology</i> </li> <li> <i>HeartBeam is the only platform capable of collecting 12-lead ECG data from patients anytime, anywhere, over time – extending access beyond traditional clinical settings</i> </li> <li> <i>Positions HeartBeam to expand from symptom-based cardiac rhythm monitoring into AI-enabled disease assessment and management</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54443010&amp;newsitemid=20260310761343&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=518c515ad0d59d148ca75231485e1ac1" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html Tue, 10 Mar 2026 07:00:00 -0400 A.00796151 A.23636062 A.30645299 A.50208664 BEAT O.00786879 O.40299161 O.41740509 O.48172734 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html <ul class="bwlistdisc"> <li> <i>Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk</i> </li> <li> <i>Combines Mount Sinai’s world-class AI and clinical expertise with HeartBeam’s groundbreaking 3D ECG signal collection technology</i> </li> <li> <i>HeartBeam is the only platform capable of collecting 12-lead ECG data from patients anytime, anywhere, over time – extending access beyond traditional clinical settings</i> </li> <li> <i>Positions HeartBeam to expand from symptom-based cardiac rhythm monitoring into AI-enabled disease assessment and management</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54443010&amp;newsitemid=20260310761343&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=518c515ad0d59d148ca75231485e1ac1" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html Tue, 10 Mar 2026 07:00:00 -0400 A.00796151 A.23636062 A.30645299 A.50208664 BEAT O.00786879 O.40299161 O.41740509 O.48172734 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html <ul class="bwlistdisc"> <li> <i>Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk</i> </li> <li> <i>Combines Mount Sinai’s world-class AI and clinical expertise with HeartBeam’s groundbreaking 3D ECG signal collection technology</i> </li> <li> <i>HeartBeam is the only platform capable of collecting 12-lead ECG data from patients anytime, anywhere, over time – extending access beyond traditional clinical settings</i> </li> <li> <i>Positions HeartBeam to expand from symptom-based cardiac rhythm monitoring into AI-enabled disease assessment and management</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54443010&amp;newsitemid=20260310761343&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=518c515ad0d59d148ca75231485e1ac1" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html Tue, 10 Mar 2026 07:00:00 -0400 A.00796151 A.23636062 A.30645299 A.50208664 BEAT O.00786879 O.40299161 O.41740509 O.48172734 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html <ul class="bwlistdisc"> <li> <i>Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk</i> </li> <li> <i>Combines Mount Sinai’s world-class AI and clinical expertise with HeartBeam’s groundbreaking 3D ECG signal collection technology</i> </li> <li> <i>HeartBeam is the only platform capable of collecting 12-lead ECG data from patients anytime, anywhere, over time – extending access beyond traditional clinical settings</i> </li> <li> <i>Positions HeartBeam to expand from symptom-based cardiac rhythm monitoring into AI-enabled disease assessment and management</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54443010&amp;newsitemid=20260310761343&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=518c515ad0d59d148ca75231485e1ac1" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html Tue, 10 Mar 2026 07:00:00 -0400 A.00796151 A.23636062 A.30645299 A.50208664 BEAT O.00786879 O.40299161 O.41740509 O.48172734 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html <ul class="bwlistdisc"> <li> <i>Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk</i> </li> <li> <i>Combines Mount Sinai’s world-class AI and clinical expertise with HeartBeam’s groundbreaking 3D ECG signal collection technology</i> </li> <li> <i>HeartBeam is the only platform capable of collecting 12-lead ECG data from patients anytime, anywhere, over time – extending access beyond traditional clinical settings</i> </li> <li> <i>Positions HeartBeam to expand from symptom-based cardiac rhythm monitoring into AI-enabled disease assessment and management</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54443010&amp;newsitemid=20260310761343&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=518c515ad0d59d148ca75231485e1ac1" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html Tue, 10 Mar 2026 07:00:00 -0400 A.00796151 A.23636062 A.30645299 A.50208664 BEAT O.00786879 O.40299161 O.41740509 O.48172734 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html <ul class="bwlistdisc"> <li> <i>Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk</i> </li> <li> <i>Combines Mount Sinai’s world-class AI and clinical expertise with HeartBeam’s groundbreaking 3D ECG signal collection technology</i> </li> <li> <i>HeartBeam is the only platform capable of collecting 12-lead ECG data from patients anytime, anywhere, over time – extending access beyond traditional clinical settings</i> </li> <li> <i>Positions HeartBeam to expand from symptom-based cardiac rhythm monitoring into AI-enabled disease assessment and management</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54443010&amp;newsitemid=20260310761343&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=518c515ad0d59d148ca75231485e1ac1" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html Tue, 10 Mar 2026 07:00:00 -0400 A.00796151 A.23636062 A.30645299 A.50208664 BEAT O.00786879 O.40299161 O.41740509 O.48172734 O.52737737 http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html <ul class="bwlistdisc"> <li> <i>Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk</i> </li> <li> <i>Combines Mount Sinai’s world-class AI and clinical expertise with HeartBeam’s groundbreaking 3D ECG signal collection technology</i> </li> <li> <i>HeartBeam is the only platform capable of collecting 12-lead ECG data from patients anytime, anywhere, over time – extending access beyond traditional clinical settings</i> </li> <li> <i>Positions HeartBeam to expand from symptom-based cardiac rhythm monitoring into AI-enabled disease assessment and management</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54443010&amp;newsitemid=20260310761343&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=518c515ad0d59d148ca75231485e1ac1" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac http://www.streetinsider.com/Press+Releases/HeartBeam+and+Mount+Sinai+Announce+Strategic+AI+Collaboration+to+Bring+Clinical-Grade+Heart+Monitoring+into+the+Home/26135123.html Tue, 10 Mar 2026 07:00:00 -0400 A.00796151 A.23636062 A.30645299 A.50208664 BEAT O.00786879 O.40299161 O.41740509 O.48172734 O.52737737